Multiple Myeloma

Multiple Myeloma is a cancer of the plasma cells, which normally is involved in antibody production. Discover the latest research on Multiple Myeloma here.

September 15, 2020
Open Access

Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells

Frontiers in Immunology
Chen ZhuMarielle Chiron
September 14, 2020

Heptamer-type small guide RNA that can shift macrophages toward the M1 state

Blood Cells, Molecules & Diseases
Tatsuya IshikawaMasayuki Nashimoto
September 17, 2020

Vitamin D and Fatigue in Palliative Cancer: A Cross-Sectional Study of Sex Difference in Baseline Data from the Palliative D Cohort

Journal of Palliative Medicine
Caritha KlassonLinda Björkhem-Bergman
September 15, 2020

Maintenance therapy in malignant oncohematology, recent advances, evolving concepts

Orvosi hetilap
Miklós Udvardy
September 17, 2020

Gaps in the Use of Long-Acting Opioids Within Intervals of Consecutive Days Among Cancer Outpatients Using Electronic Pill Caps

Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Salimah H MeghaniGeorge J Knafl
September 16, 2020
Open Access

Global analysis of SBP gene family in Brachypodium distachyon reveals its association with spike development

Scientific Reports
Rajiv K TripathiJaswinder Singh
September 15, 2020
Open Access

Characterization of the role of Samsn1 loss in multiple myeloma development

FASEB BioAdvances
Natasha L FriendAndrew C W Zannettino
September 16, 2020
Open Access

Immunomodulation in pomalidomide, dexamethasone, and daratumumab -treated relapsed/refractory multiple myeloma patients

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
William E PierceallAnjan Thakurta
September 14, 2020

Intestinal resection affects whole-body arginine synthesis in neonatal piglets

Pediatric Research
Marihan LansingRon O Ball
September 15, 2020

Syngeneic transplants for multiple myeloma - a single center experience and review of the literature

Leukemia & Lymphoma
Eyal LebelChristine Chen
September 15, 2020
Open Access

Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma

Anil K DeshantriRaymond M Schiffelers
September 17, 2020

Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from MGUS to MM

American Journal of Hematology
Charlotte GranHareth Nahi
September 15, 2020
Open Access

S1PR2 Knockdown Promotes Migration and Invasion in Multiple Myeloma Cells via NF-κB Activation

Cancer Management and Research
Meng PangHongmei Jing
September 17, 2020
Case Report

Uncommon simultaneous diagnosis of multiple myeloma and chronic myeloid leukaemia

The Journal of the Royal College of Physicians of Edinburgh
Vishal MangalDr Nachiketa
September 15, 2020

Detection of del(17p13) among newly diagnosed multiple myeloma cases using cytoplasmic light chain immunofluorescence combined with FISH and its clinical significance

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Xiupan LuRui Guo

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.


Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Adult Polyglucosan Body Disease

Adult polyglucosan body disease (APBD) is a rare autosomal recessive disease characterized by defects in the glycogen brancher enzyme 1 (GBE1) gene. Discover the latest research on APBD here.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

© 2020 Meta ULC. All rights reserved